SC
AGN

Solstein Capital’s Allergan plc AGN Stock Holding History

Solstein Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-130
Closed -$23K – 312
2020
Q1 		$23K Sell
130
-68
-34% -$12.8K 0.09% 134
2019
Q4 		$46K Buy
+198
New +$35.7K 0.09% 117

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Solstein Capital's AGN Position: Q2 2020 in Review

Solstein Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 130 shares — an estimated $23K sold.

Solstein Capital first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $46K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Solstein Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Solstein Capital sold 130 Allergan plc shares in Q2 2020, an estimated $23K.
  • Solstein Capital first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Solstein Capital's Allergan plc position peaked at $46K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Solstein Capital's 13F filing for Q2 2020, filed 12 Aug 2020.